Trademark: 79246444
Word
CANNAFEN
Status
Registered
Status Code
700
Status Date
Tuesday, June 16, 2020
Serial Number
79246444
Registration Number
6077024
Registration Date
Tuesday, June 16, 2020
Mark Type
4000
Filing Date
Friday, October 5, 2018
Published for Opposition
Tuesday, March 31, 2020

Trademark Owner History
Senzer Limited - Original Registrant

Classifications
5 Pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the nature of tablets, liquid medications, inhalers, nasal and oral sprays that facilitate the delivery of a wide range of pharmaceuticals; Transdermal patches and transdermal patches for medical treatment, both for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; all of the aforementioned goods containing cannabis that is solely synthetic in nature; sanitary preparations for medical purposes, vaccines, and sanitary sterilising preparations, all not containing cannabis or CBD
10 Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposes, sold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in nature, or containing cannabis that is solely synthetic in nature

Trademark Events
Sep 14, 2023
Withdrawal Of Attorney Granted
Sep 14, 2023
Teas Withdrawal Of Attorney Received
Jan 9, 2021
Final Decision Transaction Processed By Ib
Oct 4, 2020
Final Disposition Notice Sent To Ib
Oct 4, 2020
Final Disposition Processed
Sep 16, 2020
Final Disposition Notice Created, To Be Sent To Ib
Jun 16, 2020
Registered-Principal Register
May 15, 2020
Notification Of Possible Opposition - Processed By Ib
Apr 29, 2020
Notification Of Possible Opposition Sent To Ib
Apr 29, 2020
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 31, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 31, 2020
Published For Opposition
Mar 27, 2020
Notification Processed By Ib
Mar 11, 2020
Notification Of Possible Opposition Sent To Ib
Mar 11, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 11, 2020
Notification Of Notice Of Publication E-Mailed
Feb 27, 2020
Assigned To Lie
Feb 21, 2020
Approved For Pub - Principal Register
Feb 21, 2020
Examiner's Amendment Entered
Feb 21, 2020
Notification Of Examiners Amendment E-Mailed
Feb 21, 2020
Examiners Amendment E-Mailed
Feb 21, 2020
Examiners Amendment -Written
Jan 23, 2020
Teas/Email Correspondence Entered
Jan 22, 2020
Correspondence Received In Law Office
Jan 22, 2020
Teas Response To Office Action Received
Jul 23, 2019
Notification Of Non-Final Action E-Mailed
Jul 23, 2019
Non-Final Action E-Mailed
Jul 23, 2019
Non-Final Action Written
Jun 26, 2019
Teas/Email Correspondence Entered
Jun 25, 2019
Correspondence Received In Law Office
Jun 25, 2019
Teas Response To Office Action Received
Jun 21, 2019
Refusal Processed By Ib
May 24, 2019
New Representative At Ib Received
May 20, 2019
Notification Of Non-Final Action E-Mailed
May 20, 2019
Non-Final Action E-Mailed
May 20, 2019
Non-Final Action Written
Apr 5, 2019
Teas/Email Correspondence Entered
Apr 4, 2019
Correspondence Received In Law Office
Apr 4, 2019
Teas Response To Office Action Received
Jan 17, 2019
Refusal Processed By Ib
Dec 29, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Dec 29, 2018
Refusal Processed By Mpu
Dec 18, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Dec 17, 2018
Non-Final Action Written
Dec 12, 2018
Assigned To Examiner
Dec 11, 2018
Assigned To Examiner
Dec 4, 2018
Application Filing Receipt Mailed
Nov 30, 2018
New Application Office Supplied Data Entered
Nov 29, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24